New York State Common Retirement Fund Buys 58,064 Shares of UiPath Inc. (NYSE:PATH)

New York State Common Retirement Fund raised its holdings in UiPath Inc. (NYSE:PATH - Free Report) by 19.0% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 363,056 shares of the healthcare company's stock after buying an additional 58,064 shares during the period. New York State Common Retirement Fund owned about 0.06% of UiPath worth $9,018,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in the business. Royal London Asset Management Ltd. boosted its holdings in shares of UiPath by 5.9% during the 3rd quarter. Royal London Asset Management Ltd. now owns 139,544 shares of the healthcare company's stock worth $2,388,000 after buying an additional 7,742 shares during the period. O Shaughnessy Asset Management LLC bought a new stake in shares of UiPath during the third quarter worth approximately $203,000. Invesco Ltd. grew its position in shares of UiPath by 2.8% in the third quarter. Invesco Ltd. now owns 399,181 shares of the healthcare company's stock valued at $6,830,000 after purchasing an additional 10,863 shares during the last quarter. Symmetry Partners LLC acquired a new position in shares of UiPath in the fourth quarter valued at approximately $205,000. Finally, California Public Employees Retirement System increased its stake in shares of UiPath by 13.9% during the fourth quarter. California Public Employees Retirement System now owns 641,825 shares of the healthcare company's stock worth $15,943,000 after purchasing an additional 78,459 shares during the period. 62.50% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other UiPath news, CFO Ashim Gupta sold 16,000 shares of the business's stock in a transaction that occurred on Friday, March 15th. The shares were sold at an average price of $22.84, for a total transaction of $365,440.00. Following the sale, the chief financial officer now directly owns 87,505 shares of the company's stock, valued at approximately $1,998,614.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Over the last three months, insiders have sold 72,000 shares of company stock valued at $1,591,360. 31.03% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of brokerages have commented on PATH. KeyCorp assumed coverage on UiPath in a report on Monday, April 8th. They issued an "overweight" rating and a $27.00 price objective on the stock. Mizuho lifted their price objective on shares of UiPath from $22.00 to $25.00 and gave the stock a "neutral" rating in a research note on Thursday, March 14th. Bank of America boosted their price objective on shares of UiPath from $26.00 to $30.00 and gave the company a "buy" rating in a report on Thursday, March 14th. Truist Financial reissued a "buy" rating and set a $32.00 target price on shares of UiPath in a report on Wednesday, March 20th. Finally, Evercore ISI boosted their price target on UiPath from $24.00 to $27.00 and gave the company an "in-line" rating in a research note on Thursday, March 14th. Nine research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to data from MarketBeat.com, UiPath currently has a consensus rating of "Moderate Buy" and a consensus target price of $27.41.

UiPath Trading Up 0.2 %

UiPath stock traded up $0.05 during mid-day trading on Thursday, reaching $19.29. The company had a trading volume of 4,595,594 shares, compared to its average volume of 8,520,562. The business has a fifty day simple moving average of $21.91 and a 200 day simple moving average of $21.65. The company has a market cap of $10.97 billion, a P/E ratio of -112.88 and a beta of 1.01. UiPath Inc. has a fifty-two week low of $12.38 and a fifty-two week high of $27.87.

UiPath (NYSE:PATH - Get Free Report) last released its quarterly earnings data on Wednesday, March 13th. The healthcare company reported $0.06 earnings per share for the quarter, beating the consensus estimate of ($0.04) by $0.10. UiPath had a negative return on equity of 3.29% and a negative net margin of 6.87%. The company had revenue of $405.25 million for the quarter, compared to the consensus estimate of $383.32 million. Research analysts forecast that UiPath Inc. will post -0.04 EPS for the current year.

UiPath Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.